bluebird bio Inc (NAS:BLUE)
$ 0.4171 0.0121 (2.99%) Market Cap: 81.10 Mil Enterprise Value: 376.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

bluebird bio Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 12:35PM GMT
Release Date Price: $6.63 (-9.30%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Good morning, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Really pleased to have the team with us from bluebird this morning. Just quickly before we get started, I need to read a disclosure statement.

Please note that all important disclosures, including personal holdings disclosures are available on the Morgan Stanley public website at morganstanley.com/researchdisclosures.

So really pleased to have Andrew and Tom with me here. Maybe we should just start off, you had some management changes recently. Maybe we should just address what's going on there, and then we can jump into some of the products.

Andrew Obenshain
bluebird bio, Inc. - President, CEO & Director

Yes. We announced yesterday that Jason Coles leaving, he's actually in the audience here. So he's not -- he hasn't gone far yet. So Jason actually stepped in as CFO at a really tough time for the company in March and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot